DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 078300
NDA 078300 describes PAMIDRONATE DISODIUM, which is a drug marketed by Aesgen, Areva Pharms, Fresenius Kabi Usa, Hospira, Luitpold, Mn Pharms, Mylan Labs Ltd, Pliva Lachema, Sagent Pharms, Sun Pharma Global, Teva Pharms Usa, and West-ward Pharms Int, and is included in fourteen NDAs. It is available from six suppliers. Additional details are available on the PAMIDRONATE DISODIUM profile page.
The generic ingredient in PAMIDRONATE DISODIUM is pamidronate disodium. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
The generic ingredient in PAMIDRONATE DISODIUM is pamidronate disodium. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the pamidronate disodium profile page.
Summary for 078300
| Tradename: | PAMIDRONATE DISODIUM |
| Applicant: | Mn Pharms |
| Ingredient: | pamidronate disodium |
| Patents: | 0 |
| Therapeutic Class: | Metabolic Bone Disease Agents |
| Formulation / Manufacturing: | see details |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 30MG/VIAL | ||||
| Approval Date: | Mar 10, 2009 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 90MG/VIAL | ||||
| Approval Date: | Mar 10, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
